{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "29547436",
  "DateCompleted": {
    "Year": "2019",
    "Month": "09",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "03",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1097/QAD.0000000000001791"
    ],
    "Journal": {
      "ISSN": "1473-5571",
      "JournalIssue": {
        "Volume": "32",
        "Issue": "10",
        "PubDate": {
          "Year": "2018",
          "Month": "Jun",
          "Day": "19"
        }
      },
      "Title": "AIDS (London, England)",
      "ISOAbbreviation": "AIDS"
    },
    "ArticleTitle": "HIV-1 group P infection: towards a dead-end infection?",
    "Pagination": {
      "StartPage": "1317",
      "EndPage": "1322",
      "MedlinePgn": "1317-1322"
    },
    "Abstract": {
      "AbstractText": [
        "HIV/1 group P (HIV-1/P) is the last HIV/1 group discovered and, to date, constitutes only two strains. To obtain new insight into this divergent group, we screened for new infections by developing specific tools, and analysed phenotypic and genotypic properties of the prototypic strain RBF168. In addition, the follow-up of the unique infected patient monitored so far has raised the knowledge of the natural history of this infection and its therapeutic management.",
        "We developed an HIV-1/P specific seromolecular strategy and screened over 29\u200a498 specimen samples. Infectivity and evolution of the gag-30 position, considered as marker of adaptation to human, were explored by successive passages of RBF168 strain onto human peripheral blood mononuclear cells. Natural history and immunovirological responses to combined antiretroviral therapy (cART) were analysed based on CD4+ cells and plasmatic viral load evolution.",
        "No new infection was detected. Infectivity of RBF168 was found lower, relative to other main HIV groups and the conservative methionine found in the gag-30 position revealed a lack of adaptation to human. The follow-up of the patient during the 5-year ART-free period, showed a relative stability of CD4+ cell count with a mean of 326 cells/\u03bcl. Initiation of cART led to rapid RNA undetectability with a significant increase of CD4+ cells, reaching 687 cells/\u03bcl after 8 years.",
        "Our results showed that HIV-1/P strains remain extremely rare and could be less adapted and pathogenic than other HIV strains. These data lead to the hypothesis that HIV-1/P infection could evolve towards, or even already corresponds to, a dead-end infection."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Normandie University, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France."
          }
        ],
        "LastName": "Alessandri-Gradt",
        "ForeName": "Elodie",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Normandie University, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France."
          }
        ],
        "LastName": "De Oliveira",
        "ForeName": "Fabienne",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Normandie University, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France."
          }
        ],
        "LastName": "Leoz",
        "ForeName": "Marie",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Normandie University, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France."
          }
        ],
        "LastName": "Lemee",
        "ForeName": "V\u00e9ronique",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Evolution & Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK."
          },
          {
            "Identifier": [],
            "Affiliation": "MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom."
          }
        ],
        "LastName": "Robertson",
        "ForeName": "David L",
        "Initials": "DL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Evolution & Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Biology, University of Nevada, Reno, Nevada, USA."
          }
        ],
        "LastName": "Feyertag",
        "ForeName": "Felix",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratoire de Virologie, Centre Pasteur du Cameroun, Yaound\u00e9, Cameroun."
          }
        ],
        "LastName": "Ngoupo",
        "ForeName": "Paul-Alain",
        "Initials": "PA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Ravinala Conseil."
          }
        ],
        "LastName": "Mauclere",
        "ForeName": "Philippe",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departement de microbiologie, H\u00f4pital Saint Louis, Facult\u00e9 de m\u00e9decine Paris Diderot, Paris, France."
          }
        ],
        "LastName": "Simon",
        "ForeName": "Fran\u00e7ois",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Normandie University, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France."
          }
        ],
        "LastName": "Plantier",
        "ForeName": "Jean-Christophe",
        "Initials": "JC"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MC_UU_12014/12",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "Acronym": "BB_",
        "Agency": "Biotechnology and Biological Sciences Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "AIDS",
    "NlmUniqueID": "8710219",
    "ISSNLinking": "0269-9370"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "gag Gene Products, Human Immunodeficiency Virus"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adaptation, Biological"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Blood"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CD4 Lymphocyte Count"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cells, Cultured"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Follow-Up Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genotype"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genotyping Techniques"
    },
    {
      "QualifierName": [
        "drug therapy",
        "pathology",
        "virology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Leukocytes, Mononuclear"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation, Missense"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Serotyping"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Load"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virulence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Cultivation"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "gag Gene Products, Human Immunodeficiency Virus"
    }
  ]
}